Heart failure trials recruiting in Michigan

All Heart failure trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
  NCT05489705 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Grand Rapids, West Bloomfield
• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
  NCT07214376 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Detroit
• A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
  NCT06979362 · Phase: Phase 2 · Ages: 40 Years to 84 Years · Sex: All (male and female) · Michigan: Detroit
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Bloomfield Hills, Grand Rapids, Lansing, Southfield
• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Michigan: Ypsilanti
• A Study of LY3971297 in Participants With Heart Failure
  NCT07547540 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Michigan: Detroit
• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
  NCT06056297 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Flint, Southfield, Troy
• A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07192952 · Phase: Phase 3 · Ages: Up to 18 Years · Sex: All (male and female) · Michigan: Ann Arbor
• A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
  NCT07188805 · Phase: Phase 3 · Ages: 6 Months to 17 Years · Sex: All (male and female) · Michigan: Ann Arbor
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
  NCT06935370 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Bloomfield Hills, Farmington Hills, Southfield, Ypsilanti
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
  NCT06424288 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Dearborn, Lansing, Southfield, Ypsilanti
• A Trial of CRD-4730 in HFrEF
  NCT07750873 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Bloomfield Hills
• AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
  NCT06699056 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
  NCT06932081 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Grand Rapids
• Alleviant ALLAY-HF Study
  NCT05685303 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit, Southfield, Ypsilanti
• CCM OPEN HF Registry
  NCT07112924 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Novi, Ypsilanti
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit, Farmington Hills
• CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
  NCT05996328 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction
  NCT06258447 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 90 Years · Sex: All (male and female) · Michigan: Detroit
• Cardiovascular Health Improvement Project
  NCT02306200 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Kalamazoo, Pontiac, Roseville, Saint Clair Shores
• Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
  NCT06964464 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
  NCT05677100 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
  NCT01790152 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Detroit, Flint
• Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
  NCT05714085 · Phase: Phase 2, Phase 3 · Ages: 29 Days to 17 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
  NCT04592445 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
  NCT03836482 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
  NCT06337812 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
  NCT06898515 · Phase: Phase 3 · Ages: 22 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Grand Rapids, Royal Oak
• HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
  NCT05784753 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
  NCT06291922 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
  NCT06310031 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · Michigan: Ann Arbor, Detriot, Grand Rapids
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
  NCT07288398 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Ann Arbor, Ypsilanti
• MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
  NCT05933083 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Michigan: Ann Arbor, Bloomfield Township, Detroit, Grand Rapids
• Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
  NCT07490067 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
  NCT06532890 · Phase: Not specified · Ages: Up to 18 Years · Sex: All (male and female) · Michigan: Ann Arbor
• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
  NCT05934487 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Howell
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Farmington Hills, Flint, Troy, Ypsilanti
• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  NCT00271180 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Lansing, Marquette, Ypsilanti
• Project 2: ACHIEVE- HF
  NCT05330221 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Project 4: ACHIEVE PATHFINDER
  NCT06070428 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
  NCT06777368 · Phase: Not specified · Ages: 18 Years to 105 Years · Sex: All (male and female) · Michigan: Ann Arbor, Detroit, Grand Rapids
• Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
  NCT07069738 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Grand Rapids
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Michigan: Ann Arbor, Grand Blanc
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
  NCT06736574 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Michigan: Detroit
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · Michigan: Ann Arbor, Bloomfield Hills, Dearborn, Farmington Hills
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
  NCT03142152 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Royal Oak, Saginaw
• The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
  NCT07098858 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit, Grand Rapids
• UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
  NCT07054489 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · Michigan: Detroit
• Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
  NCT05459233 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Royal Oak